Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $26.8 Million - $29.2 Million
86,600 Added 84.0%
189,700 $61.1 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $9.88 Million - $12 Million
-37,600 Reduced 26.72%
103,100 $32.2 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $16.2 Million - $19.5 Million
-60,200 Reduced 29.97%
140,700 $40 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $39.5 Million - $44.5 Million
154,400 Added 332.04%
200,900 $57.9 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $1.48 Million - $1.75 Million
6,900 Added 17.42%
46,500 $10.3 Million
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $18.5 Million - $22.6 Million
-82,000 Reduced 67.43%
39,600 $9.57 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $3.64 Million - $4.63 Million
15,900 Added 15.04%
121,600 $31.9 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $11.4 Million - $12.8 Million
50,600 Added 91.83%
105,700 $23.8 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $1.38 Million - $1.54 Million
6,000 Added 12.22%
55,100 $13.4 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $3.77 Million - $4.17 Million
-17,200 Reduced 25.94%
49,100 $11.9 Million
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $11.1 Million - $12.7 Million
-56,000 Reduced 45.79%
66,300 $14.9 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $42.3 Million - $49.6 Million
-199,400 Reduced 61.98%
122,300 $26 Million
Q2 2021

Sep 13, 2021

BUY
$233.58 - $259.14 $75.1 Million - $83.4 Million
321,700 New
321,700 $78.4 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.